z-logo
open-access-imgOpen Access
Cutting Edge: Ectopic Expression of CD40 Ligand on B Cells Induces Lupus-Like Autoimmune Disease
Author(s) -
Tetsuya Higuchi,
Yuichi Aiba,
Takashi Nomura,
Junichiro Matsuda,
Keiji Mochida,
Misao Suzuki,
Hitoshi Kikutani,
Tasuku Honjo,
Kiyoshi Nishioka,
Takeshi Tsubata
Publication year - 2002
Publication title -
the journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.737
H-Index - 372
eISSN - 1550-6606
pISSN - 0022-1767
DOI - 10.4049/jimmunol.168.1.9
Subject(s) - cd40 , systemic lupus erythematosus , ectopic expression , autoantibody , anti nuclear antibody , transgene , autoimmune disease , immunology , immune system , genetically modified mouse , autoimmunity , biology , disease , medicine , pathology , antibody , cell culture , gene , cytotoxic t cell , genetics , in vitro
CD40 ligand (CD40L) is ectopically expressed on B cells in patients with systemic lupus erythematosus (SLE) and lupus-prone BXSB mice. To assess the role of the ectopic CD40L expression in development of SLE, we have established transgenic mice expressing CD40L on B cells. Some of the 12- to 14-mo-old CD40L-transgenic mice spontaneously produced autoantibodies such as antinuclear Abs, anti-DNA Abs, and antihistone Abs. Moreover, approximately half of the transgenic mice developed glomerulonephritis with immune-complex deposition, whereas the kidneys of the normal littermates showed either no pathological findings or only mild histological changes. These results indicate that CD40L on B cells causes lupus-like disease in the presence of yet unknown environmental factors that by themselves do not induce the disease. Thus, ectopic CD40L expression on B cells may play a crucial role in development of SLE.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom